Protect your company, its assets, directors, and officers with effective insurance and risk management technique.The medical and scientific advances that are being made in the 21st century are providing for new innovations and discoveries. Critical research and development (R&D) investments, rigorous clinical trials, access to capital, ongoing regulatory hurdles all result in market volatility and increased likelihood of litigation for emerging life science companies. Through all of this, you need a trusted partner to protect your company, its assets and directors and officers from peril with effective insurance and risk management techniques.EWI has developed unparalleled expertise in the multitude of tort liability exposures specific to biotechnology, medical device and pharmaceutical companies. We offer customized strategies to mitigate exposures, taking into account the exposures inherent to a specific company and the overall dynamics of plaintiffs' bar view toward the biotechnology, medical device and pharmaceutical industries. Through a risk assessment process, we analyze an organization's operational, strategic, and financial risks, and develop appropriate solutions to avoid, mitigate, or transfer those risks. Traditional risk-transfer programs: |
||
|
||
| In addition, EWI's consultative approach to risk management not only helps our life sciences client's better manage their risk exposures, but also aids in the underwriting and risk placement process resulting in a reduced cost-of risk. | ||